Skip to Content

Month: February 2021

Rheumatoid arthritis drug reduces risk of death for severely ill hospitalized Covid-19 patients, researchers say

Tocilizumab, an intravenous anti-inflammatory drug used for rheumatoid arthritis, has been shown to reduce the risk of death for patients hospitalized with severe Covid-19, as well as reducing the risk of ventilation and the amount of time until discharged from hospital. The preliminary results came from the RECOVERY trial, which has been testing potential Covid-19

Continue Reading
Skip to content